FDA
-
-
-
-
-
-
-
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
-
-
-
-
-
-
-
ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)
-
-
-
-
-
-
-
ABVC BioPharma, Inc (ABVC) Provides 2023 Pipeline Update
-
-
-
-
-
-
-
ABVC BioPharma (ABVC) Issues Letter to Shareholders
-
-
-
-
-
-
-
ABVC BioPharma (ABVC) Provides Vitargus Update
-
-
-
-
-
-
-
ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
-
-
-
-
-
-
-
ABVC BioPharma, Inc (ABVC) Announces $3M Clinical Services Contract with NeuCen BioMed
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

